Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy

Quality of Life Research

Volumn 19, Issue 4, 2010, Pages 531-537

  Ostacoli, Luca ^a   Saini, Andrea ^a   Ferini Strambi, Luigi ^b   Castronovo, Vincenza ^b   Sguazzotti, Erica ^a   Picci, Rocco Luigi ^a   Toje, Mario ^a   Gorzegno, Gabriella ^a   Capogna, Serena ^a   Dongiovanni, Vincenzo ^c   Dogliotti, Luigi ^a   Furlan, Pier Maria ^a   Berruti, Alfredo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c ASL 8   (Italy)

Author keywords

Cancer; Depression; Quality of life; Restless legs syndrome

Indexed keywords

ANTINEOPLASTIC AGENT;

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CHEMICALLY INDUCED DISORDER; CONFIDENCE INTERVAL; DEPRESSION; FEMALE; HEALTH SURVEY; HUMAN; ITALY; MALE; MENTAL STRESS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PREVALENCE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RISK; RISK FACTOR; STATISTICAL MODEL;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANXIETY; CONFIDENCE INTERVALS; DEPRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; ODDS RATIO; PREVALENCE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; RISK FACTORS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 77956394668     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-010-9614-8     Document Type: Article

References (27)

1. Sateia, M. J., & Lang, B. J. (2008). Sleep and cancer: Recent developments. Current Oncology Reports, 10, 309-318.
2. Lis, C. G., Gupta, D., & Grutsch, J. F. (2008). The relationship between insomnia and patient satisfaction with quality of life in cancer. Supportive Care in Cancer, 16, 261-266.
3. Broman, J. E., Mallon, L., & Hetta, J. (2008). Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: Epidemiological survey in Sweden. Psychiatry and Clinical Neurosciences, 62, 472-475.
4. Montplaisir, J., Allen, R., Walters, S. A., Ferini-Strambi, L. (2005). Restless legs syndrome and periodic limb movements during sleep. In M. H. Kryger, T. Roth, W. C. Dement (Eds), Principles and practice of sleep medicine (pp. 839-852). Philadelphia: Elsevier-Saunders.
5. Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisir, J. (2003). Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology: A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine, 4, 101-119.
6. Earley, C. J. (2003). Restless legs syndrome. New England Journal of Medicine, 348, 2103-2109.
7. Atlas Task Force of the American Sleep Disorders Association. (1993). Recording and scoring of leg movements. Sleep, 16, 748-759.
8. Hening, W., Allen, R., Walters, A. S., Brown, T., & Montplaisir, J. (2003). Prevalence of restless legs syndrome (RLS) and impact of symptoms on the quality of life of sufferers. European Journal of Neurology, 10, S43.
9. Berger, K., Luedemann, J., Trenkwalder, C., John, U.,& Kessler, C. (2004). Sex and the risk of restless legs syndrome in the general population. Archives of Internal Medicine, 164, 196-202.
10. Allen, R., Walters, A. S., Montplaisir, J., Hening, W., Myers, A., Bell, T. J., et al. (2005). Restless legs syndrome prevalence and impact: REST general population study. Archives of Internal Medicine, 165, 1286-1292.
11. Hening, W., Walters, A. S., Allen, R. P., Montplaisir, J., Myers, A., & Ferini-Strambi, L. (2004). Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: The REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Medicine, 5, 237-246.
12. Allen, R. P. (2007). Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. American Journal of Medicine, 120, S13-S21.
13. Comella, C. L. (2002). Restless legs syndrome: Treatment with dopaminergic agents. Neurology, 58, S87-S92.
14. Davidson, J. R., MacLean, A. W., Brundage, M. D., & Schulze, K. (2002). Sleep disturbances in cancer patients. Social Science and Medicine, 54, 1309-1321.
15. Cella, D. F., Tulsky, D. S., Gray, G., et al. (1993). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570-579.
16. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370.
17. Watson, M., Law, M., dos Santos, M., Greer, S., & Baruch, J. (1994). Bliss J. The mini-MAC: Further development of the mental adjustment to cancer scale psychosoc oncol, 12, 33-46.
18. Grassi, L., Buda, P., Cavana, L., Annunziata, M. A., Torta, R., & Varetto, A. (2005). Styles of coping with cancer: The Italian version of the mini-mental adjustment to cancer scale. Psycho- Oncol, 14, 115-224.
19. Ferini-Strambi, L. (2007). RLS-like symptoms: Differential diagnosis by history and clinical assessment. Sleep Medicine, 2, S3-S6.
20. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
21. Korpacka, M. K., Matusiewicz, M., Diakowska, D., et al. (2009). Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors. Experimental Oncology, 31, 52-56.
22. Ekbom, K. A. (1960). Restless legs syndrome. Neurology, 10, 868-873.
23. Kushida, C., Martin, C., Nikam, P., Blaisdell, B., Wallenstein, G., Ferini Strambi, L., et al. (2007). Burdenof restless legs syndrome on health-related quality of life. Quality of Life Research, 16, 617-624.
24. Wittmack, T. (1861). Pathologie und Therapie der Sensibilitat- Neurosen. Leipzig: E. Schafer.
25. Picchietti, D., & Winkelmann, J. W. (2005). Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep, 28, 891-898.
26. Cankurtaran, E. S., Ozalp, E., Soygur, H., et al. (2008). Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: Superiority over imipramine. Supportive Care in Cancer, 16, 1291-1298.
27. Rottach, K., Schaner, B., Kirch, M., et al. (2009). Restless legs syndrome as a side effect of second generation antidepressants. Journal of Psychiatric Research, 43, 70-75.